ArticleJournal of personalized medicine2022

Risk of Post-Myocardial Infarction Pneumonia with Proton Pump Inhibitors, H2 Receptor Antagonists and Mucoprotective Agents: A Retrospective Nationwide Cohort Study.

Jimin Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.